Cyclo Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Cyclo Therapeutics

09/08/2024 22:10

* Cyclo Therapeutics Inc  CYTH.OQ   CYTH.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 12
(estimated) for the period ending June 30 2024
    * The Gainesville Florida Florida-based  company is expected
to
report a 128.6% increase in revenue to $267.5 thousand from $117
thousand a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Cyclo Therapeutics Inc
is for
a loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cyclo
Therapeutics Inc is $3.00​, above​ its last closing price
of $1.21. ​​​

This summary was machine generated August 9 at 21:10 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)